AssetMark Inc
FOLD

AssetMark Inc’s Amicus Therapeutics FOLD Stock Holding History

AssetMark Inc’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-64
Closed -$367 – 3222
2025
Q2 		$367 Sell
64
-14,778
-100% -$95.4K ﹤0.01% 2793
2025
Q1 		$121K Sell
14,842
-96,746
-87% -$895K ﹤0.01% 1239
2024
Q4 		$1.05M Sell
111,588
-8,499
-7% -$88.3K ﹤0.01% 844
2024
Q3 		$1.28M Sell
120,087
-39,781
-25% -$433K ﹤0.01% 742
2024
Q2 		$1.59M Buy
159,868
+42,061
+36% +$432K ﹤0.01% 670
2024
Q1 		$1.39M Buy
117,807
+22,064
+23% +$282K ﹤0.01% 655
2023
Q4 		$1.36M Buy
95,743
+25,082
+35% +$285K ﹤0.01% 604
2023
Q3 		$859K Buy
70,661
+13,725
+24% +$177K ﹤0.01% 644
2023
Q2 		$715K Buy
56,936
+12,278
+27% +$146K ﹤0.01% 665
2023
Q1 		$495K Buy
44,658
+7,152
+19% +$88.2K ﹤0.01% 715
2022
Q4 		$458K Buy
37,506
+16,936
+82% +$191K ﹤0.01% 713
2022
Q3 		$215K Buy
20,570
+8,543
+71% +$95.2K ﹤0.01% 754
2022
Q2 		$129K Buy
12,027
+9,372
+353% +$77.2K ﹤0.01% 788
2022
Q1 		$25K Buy
+2,655
New +$24.9K ﹤0.01% 1037

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AssetMark Inc's FOLD Position: Q3 2025 in Review

AssetMark Inc sold out of Amicus Therapeutics (FOLD) in Q3 2025, closing a stake of 64 shares — an estimated $367 sold.

AssetMark Inc first reported a position in FOLD in Q1 2022 and held it in 14 quarters. The position peaked at $1.59M in Q2 2024. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • AssetMark Inc reported no remaining Amicus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • AssetMark Inc sold 64 Amicus Therapeutics shares in Q3 2025, an estimated $367.
  • AssetMark Inc first reported a position in Amicus Therapeutics in Q1 2022 and held it in 14 quarters.
  • AssetMark Inc's Amicus Therapeutics position peaked at $1.59M in Q2 2024.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on AssetMark Inc's 13F filing for Q3 2025, filed 6 Nov 2025.